Corticobasal Ganglionic DegenerationAuthor :
Hardback
Published : Friday 3 February 2006
Description
The clinical syndrome of asymmetric parkinsonism associated with cortical abnormalities along with peculiar pathology come to be known as corticobasal ganglionic degeneration (CBGD), actually defined simply as corticobasal degeneration (CBD). The definition of the clinical syndrome of CBD is still evolving. Ideally, the complete and accurate characterisation of the clinical syndrome is contingent on diagnosing all subjects who have the disease and excluding subjects who do not. The apparent rarity of the disease makes it a formidable task to accumulate a sufficient number of cases to analyse and obtain meaningful results, as well as making it difficult for physicians to gain familiarity with and to recognise the syndrome. The aim of this work will be to determine the nature of CBD, its clinical impact and its cortical involvement, by evaluating functional imaging and cognitive neuropsychological evaluation.
You may also like ...
by
Hardback
18 Sep 2006
Cardiovascular medicine
€191.87
Extended stock – Dispatch 5-7 days
by
Hardback
03 Feb 2006
Neurology and clinical neurophysiology
€176.66
Extended stock – Dispatch 5-7 days
by
Hardback
30 Jun 2004
Physiological and neuro-psychology, biopsychology
€119.33
Extended stock – Dispatch 5-7 days
by
Hardback
18 Jul 2024
Thriller / suspense fiction
€19.88
Reviews